Dr. Thomas D. Shellenberger, MD

Dr. Shellenberger practices at Banner MD Anderson Cancer Center at Banner - University Medical Center Phoenix in Phoenix, Arizona.

Dr. Shellenberger's NPI, 1730141391, was assigned on April 6, 2006. Dr. Shellenberger graduated from University of Miami, Lm Miller School of Medicine in 1995. Dr. Shellenberger holds Arizona license 46704.

Dr. Shellenberger's primary practice is Banner MD Anderson Cancer Center at Banner - University Medical Center Phoenix, at 925 E McDowell Rd, Phoenix, AZ 85006 in Maricopa County. The practice phone is (602) 747-4000.

Dr. Shellenberger's primary practice is Banner MD Anderson Cancer Center at Banner - University Medical Center Phoenix in Phoenix, Arizona. Dr. Shellenberger is also affiliated with Banner - University Medical Center Phoenix. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Shellenberger to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shellenberger practices, 8 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Shellenberger's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Shellenberger is licensed in Arizona.

CMS data shows 489 Medicare services from Dr. Shellenberger across 8 procedure codes in 2024, for 306 Medicare patients. Medicare paid $29,200 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 306 Medicare patients who saw Dr. Shellenberger in 2024. The largest group is 75 to 84, with 145 patients. 74% of them have high cholesterol, and 73% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shellenberger's median patient age at 71, with 42% women.

In 2024, Dr. Shellenberger wrote 130 Medicare Part D claims for 65 patients. 76% of them were for generic drugs. CMS names the drug for 79 of them, across 3 drugs with 11 or more claims each, at $1,638 in total drug cost. In 2023, CMS named 89 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Shellenberger for performance year 2024, reported as part of a group. Dr. Shellenberger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of melanoma (skin cancer) excision by Dr. Shellenberger, more than 71% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Shellenberger, published from 2013 to 2024. The most frequent topics are Head and Neck Neoplasms, Quality Indicators, Health Care and Patient Care Team. Dr. Shellenberger has published most often in Oral Maxillofac Surg Clin North Am. Dr. Shellenberger's most frequent co-authors are Zvonimir Luka Milas, MD, Randal S. Weber, MD and Iram Ahmad, MD.

CMS Open Payments shows 16 general payments to Dr. Shellenberger from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $339.

Dr. Shellenberger graduated from University of Miami, Lm Miller School of Medicine in 1995.